MedicaidCoverageMedium impact
MMP 24-37: Termination of COVID-19 Home Test Kit Coverage and Special Reimbursement for COVID-19 Specimen Collection and Clinic Vaccine Administration
Michigan Medicaid - MDHHS·MI · Family Medicine, Internal Medicine, General Practice +1 more·Claims & Billing
Effective date
Oct 1, 2024
We identified it
Jun 20, 2026
Summary
Michigan Medicaid is terminating coverage for over-the-counter COVID-19 home test kits and ending special reimbursement for COVID-19 specimen collection and vaccine administration services. Laboratory-performed COVID-19 tests will continue to be covered but must meet traditional medical necessity requirements.
Action Required
By October 1, 2024: Billing team must stop billing for over-the-counter COVID-19 home test kits for Michigan Medicaid patients. Discontinue separate billing for COVID-19 specimen collection services - these will now be included in lab test processing or E&M service reimbursement. For FQHCs, RHCs, THCs, and Tribal FQHCs, stop using special COVID-19 vaccine administration billing and revert to standard clinic reimbursement policies. Ensure all laboratory-performed COVID-19 tests meet medical necessity requirements per traditional Medicaid laboratory policy.